Global Recombinant Coagulation Factor Concentrate Supply, Demand and Key Producers, 2023-2029

Global Recombinant Coagulation Factor Concentrate Supply, Demand and Key Producers, 2023-2029

Page: 129

Published Date: 22 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Recombinant Coagulation Factor Concentrate market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

This report studies the global Recombinant Coagulation Factor Concentrate production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Coagulation Factor Concentrate, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Coagulation Factor Concentrate that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Coagulation Factor Concentrate total production and demand, 2018-2029, (K Units)
Global Recombinant Coagulation Factor Concentrate total production value, 2018-2029, (USD Million)
Global Recombinant Coagulation Factor Concentrate production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Coagulation Factor Concentrate consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Coagulation Factor Concentrate domestic production, consumption, key domestic manufacturers and share
Global Recombinant Coagulation Factor Concentrate production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Coagulation Factor Concentrate production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Coagulation Factor Concentrate production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Recombinant Coagulation Factor Concentrate market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Alprolix, Benefix, Idelvion, Lxinity, Rebinyn, Rixubis, CSL and Baxalta, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Coagulation Factor Concentrate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Coagulation Factor Concentrate Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Recombinant Coagulation Factor Concentrate Market, Segmentation by Type
250 IU
500 IU
1000 IU
2000 IU

Global Recombinant Coagulation Factor Concentrate Market, Segmentation by Application
Hopistial
Clinic
Others

Companies Profiled:
Bayer
Alprolix
Benefix
Idelvion
Lxinity
Rebinyn
Rixubis
CSL
Baxalta
Sanofi
Biogen
Pfizer
Novo Disk
Baxter
Wyeth
北京天坛生物制品股份有限公司
上海莱士
泰邦生物
华兰生物
绿十字(中国)生物制品有限公司

Key Questions Answered
1. How big is the global Recombinant Coagulation Factor Concentrate market?
2. What is the demand of the global Recombinant Coagulation Factor Concentrate market?
3. What is the year over year growth of the global Recombinant Coagulation Factor Concentrate market?
4. What is the production and production value of the global Recombinant Coagulation Factor Concentrate market?
5. Who are the key producers in the global Recombinant Coagulation Factor Concentrate market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Recombinant Coagulation Factor Concentrate Introduction
1.2 World Recombinant Coagulation Factor Concentrate Supply & Forecast
1.2.1 World Recombinant Coagulation Factor Concentrate Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.2.3 World Recombinant Coagulation Factor Concentrate Pricing Trends (2018-2029)
1.3 World Recombinant Coagulation Factor Concentrate Production by Region (Based on Production Site)
1.3.1 World Recombinant Coagulation Factor Concentrate Production Value by Region (2018-2029)
1.3.2 World Recombinant Coagulation Factor Concentrate Production by Region (2018-2029)
1.3.3 World Recombinant Coagulation Factor Concentrate Average Price by Region (2018-2029)
1.3.4 North America Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.3.5 Europe Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.3.6 China Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.3.7 Japan Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Coagulation Factor Concentrate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Coagulation Factor Concentrate Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Recombinant Coagulation Factor Concentrate Demand (2018-2029)
2.2 World Recombinant Coagulation Factor Concentrate Consumption by Region
2.2.1 World Recombinant Coagulation Factor Concentrate Consumption by Region (2018-2023)
2.2.2 World Recombinant Coagulation Factor Concentrate Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.4 China Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.5 Europe Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.6 Japan Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.7 South Korea Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.8 ASEAN Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.9 India Recombinant Coagulation Factor Concentrate Consumption (2018-2029)

3 World Recombinant Coagulation Factor Concentrate Manufacturers Competitive Analysis
3.1 World Recombinant Coagulation Factor Concentrate Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Coagulation Factor Concentrate Production by Manufacturer (2018-2023)
3.3 World Recombinant Coagulation Factor Concentrate Average Price by Manufacturer (2018-2023)
3.4 Recombinant Coagulation Factor Concentrate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Coagulation Factor Concentrate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Coagulation Factor Concentrate in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Coagulation Factor Concentrate in 2022
3.6 Recombinant Coagulation Factor Concentrate Market: Overall Company Footprint Analysis
3.6.1 Recombinant Coagulation Factor Concentrate Market: Region Footprint
3.6.2 Recombinant Coagulation Factor Concentrate Market: Company Product Type Footprint
3.6.3 Recombinant Coagulation Factor Concentrate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Recombinant Coagulation Factor Concentrate Production Value Comparison
4.1.1 United States VS China: Recombinant Coagulation Factor Concentrate Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Coagulation Factor Concentrate Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Coagulation Factor Concentrate Production Comparison
4.2.1 United States VS China: Recombinant Coagulation Factor Concentrate Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Coagulation Factor Concentrate Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Coagulation Factor Concentrate Consumption Comparison
4.3.1 United States VS China: Recombinant Coagulation Factor Concentrate Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Coagulation Factor Concentrate Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Coagulation Factor Concentrate Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023)
4.5 China Based Recombinant Coagulation Factor Concentrate Manufacturers and Market Share
4.5.1 China Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023)
4.6 Rest of World Based Recombinant Coagulation Factor Concentrate Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023)

5 Market Analysis by Type
5.1 World Recombinant Coagulation Factor Concentrate Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 250 IU
5.2.2 500 IU
5.2.3 1000 IU
5.2.4 2000 IU
5.3 Market Segment by Type
5.3.1 World Recombinant Coagulation Factor Concentrate Production by Type (2018-2029)
5.3.2 World Recombinant Coagulation Factor Concentrate Production Value by Type (2018-2029)
5.3.3 World Recombinant Coagulation Factor Concentrate Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Recombinant Coagulation Factor Concentrate Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hopistial
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Recombinant Coagulation Factor Concentrate Production by Application (2018-2029)
6.3.2 World Recombinant Coagulation Factor Concentrate Production Value by Application (2018-2029)
6.3.3 World Recombinant Coagulation Factor Concentrate Average Price by Application (2018-2029)

7 Company Profiles
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Recombinant Coagulation Factor Concentrate Product and Services
7.1.4 Bayer Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Alprolix
7.2.1 Alprolix Details
7.2.2 Alprolix Major Business
7.2.3 Alprolix Recombinant Coagulation Factor Concentrate Product and Services
7.2.4 Alprolix Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Alprolix Recent Developments/Updates
7.2.6 Alprolix Competitive Strengths & Weaknesses
7.3 Benefix
7.3.1 Benefix Details
7.3.2 Benefix Major Business
7.3.3 Benefix Recombinant Coagulation Factor Concentrate Product and Services
7.3.4 Benefix Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Benefix Recent Developments/Updates
7.3.6 Benefix Competitive Strengths & Weaknesses
7.4 Idelvion
7.4.1 Idelvion Details
7.4.2 Idelvion Major Business
7.4.3 Idelvion Recombinant Coagulation Factor Concentrate Product and Services
7.4.4 Idelvion Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Idelvion Recent Developments/Updates
7.4.6 Idelvion Competitive Strengths & Weaknesses
7.5 Lxinity
7.5.1 Lxinity Details
7.5.2 Lxinity Major Business
7.5.3 Lxinity Recombinant Coagulation Factor Concentrate Product and Services
7.5.4 Lxinity Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lxinity Recent Developments/Updates
7.5.6 Lxinity Competitive Strengths & Weaknesses
7.6 Rebinyn
7.6.1 Rebinyn Details
7.6.2 Rebinyn Major Business
7.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Product and Services
7.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Rebinyn Recent Developments/Updates
7.6.6 Rebinyn Competitive Strengths & Weaknesses
7.7 Rixubis
7.7.1 Rixubis Details
7.7.2 Rixubis Major Business
7.7.3 Rixubis Recombinant Coagulation Factor Concentrate Product and Services
7.7.4 Rixubis Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Rixubis Recent Developments/Updates
7.7.6 Rixubis Competitive Strengths & Weaknesses
7.8 CSL
7.8.1 CSL Details
7.8.2 CSL Major Business
7.8.3 CSL Recombinant Coagulation Factor Concentrate Product and Services
7.8.4 CSL Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 CSL Recent Developments/Updates
7.8.6 CSL Competitive Strengths & Weaknesses
7.9 Baxalta
7.9.1 Baxalta Details
7.9.2 Baxalta Major Business
7.9.3 Baxalta Recombinant Coagulation Factor Concentrate Product and Services
7.9.4 Baxalta Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Baxalta Recent Developments/Updates
7.9.6 Baxalta Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi Recombinant Coagulation Factor Concentrate Product and Services
7.10.4 Sanofi Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Biogen
7.11.1 Biogen Details
7.11.2 Biogen Major Business
7.11.3 Biogen Recombinant Coagulation Factor Concentrate Product and Services
7.11.4 Biogen Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Biogen Recent Developments/Updates
7.11.6 Biogen Competitive Strengths & Weaknesses
7.12 Pfizer
7.12.1 Pfizer Details
7.12.2 Pfizer Major Business
7.12.3 Pfizer Recombinant Coagulation Factor Concentrate Product and Services
7.12.4 Pfizer Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Pfizer Recent Developments/Updates
7.12.6 Pfizer Competitive Strengths & Weaknesses
7.13 Novo Disk
7.13.1 Novo Disk Details
7.13.2 Novo Disk Major Business
7.13.3 Novo Disk Recombinant Coagulation Factor Concentrate Product and Services
7.13.4 Novo Disk Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Novo Disk Recent Developments/Updates
7.13.6 Novo Disk Competitive Strengths & Weaknesses
7.14 Baxter
7.14.1 Baxter Details
7.14.2 Baxter Major Business
7.14.3 Baxter Recombinant Coagulation Factor Concentrate Product and Services
7.14.4 Baxter Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Baxter Recent Developments/Updates
7.14.6 Baxter Competitive Strengths & Weaknesses
7.15 Wyeth
7.15.1 Wyeth Details
7.15.2 Wyeth Major Business
7.15.3 Wyeth Recombinant Coagulation Factor Concentrate Product and Services
7.15.4 Wyeth Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Wyeth Recent Developments/Updates
7.15.6 Wyeth Competitive Strengths & Weaknesses
7.16 北京天坛生物制品股份有限公司
7.16.1 北京天坛生物制品股份有限公司 Details
7.16.2 北京天坛生物制品股份有限公司 Major Business
7.16.3 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Product and Services
7.16.4 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 北京天坛生物制品股份有限公司 Recent Developments/Updates
7.16.6 北京天坛生物制品股份有限公司 Competitive Strengths & Weaknesses
7.17 上海莱士
7.17.1 上海莱士 Details
7.17.2 上海莱士 Major Business
7.17.3 上海莱士 Recombinant Coagulation Factor Concentrate Product and Services
7.17.4 上海莱士 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 上海莱士 Recent Developments/Updates
7.17.6 上海莱士 Competitive Strengths & Weaknesses
7.18 泰邦生物
7.18.1 泰邦生物 Details
7.18.2 泰邦生物 Major Business
7.18.3 泰邦生物 Recombinant Coagulation Factor Concentrate Product and Services
7.18.4 泰邦生物 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 泰邦生物 Recent Developments/Updates
7.18.6 泰邦生物 Competitive Strengths & Weaknesses
7.19 华兰生物
7.19.1 华兰生物 Details
7.19.2 华兰生物 Major Business
7.19.3 华兰生物 Recombinant Coagulation Factor Concentrate Product and Services
7.19.4 华兰生物 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 华兰生物 Recent Developments/Updates
7.19.6 华兰生物 Competitive Strengths & Weaknesses
7.20 绿十字(中国)生物制品有限公司
7.20.1 绿十字(中国)生物制品有限公司 Details
7.20.2 绿十字(中国)生物制品有限公司 Major Business
7.20.3 绿十字(中国)生物制品有限公司 Recombinant Coagulation Factor Concentrate Product and Services
7.20.4 绿十字(中国)生物制品有限公司 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 绿十字(中国)生物制品有限公司 Recent Developments/Updates
7.20.6 绿十字(中国)生物制品有限公司 Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Recombinant Coagulation Factor Concentrate Industry Chain
8.2 Recombinant Coagulation Factor Concentrate Upstream Analysis
8.2.1 Recombinant Coagulation Factor Concentrate Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Coagulation Factor Concentrate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Coagulation Factor Concentrate Production Mode
8.6 Recombinant Coagulation Factor Concentrate Procurement Model
8.7 Recombinant Coagulation Factor Concentrate Industry Sales Model and Sales Channels
8.7.1 Recombinant Coagulation Factor Concentrate Sales Model
8.7.2 Recombinant Coagulation Factor Concentrate Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Recombinant Coagulation Factor Concentrate Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Coagulation Factor Concentrate Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Coagulation Factor Concentrate Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Coagulation Factor Concentrate Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Coagulation Factor Concentrate Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Coagulation Factor Concentrate Production Market Share by Region (2018-2023)
Table 9. World Recombinant Coagulation Factor Concentrate Production Market Share by Region (2024-2029)
Table 10. World Recombinant Coagulation Factor Concentrate Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Coagulation Factor Concentrate Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Coagulation Factor Concentrate Major Market Trends
Table 13. World Recombinant Coagulation Factor Concentrate Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Coagulation Factor Concentrate Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Coagulation Factor Concentrate Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Coagulation Factor Concentrate Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Coagulation Factor Concentrate Producers in 2022
Table 18. World Recombinant Coagulation Factor Concentrate Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Coagulation Factor Concentrate Producers in 2022
Table 20. World Recombinant Coagulation Factor Concentrate Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Coagulation Factor Concentrate Company Evaluation Quadrant
Table 22. World Recombinant Coagulation Factor Concentrate Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Coagulation Factor Concentrate Production Site of Key Manufacturer
Table 24. Recombinant Coagulation Factor Concentrate Market: Company Product Type Footprint
Table 25. Recombinant Coagulation Factor Concentrate Market: Company Product Application Footprint
Table 26. Recombinant Coagulation Factor Concentrate Competitive Factors
Table 27. Recombinant Coagulation Factor Concentrate New Entrant and Capacity Expansion Plans
Table 28. Recombinant Coagulation Factor Concentrate Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Coagulation Factor Concentrate Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Coagulation Factor Concentrate Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Coagulation Factor Concentrate Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share (2018-2023)
Table 37. China Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share (2018-2023)
Table 47. World Recombinant Coagulation Factor Concentrate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Coagulation Factor Concentrate Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Coagulation Factor Concentrate Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Coagulation Factor Concentrate Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Coagulation Factor Concentrate Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Coagulation Factor Concentrate Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Coagulation Factor Concentrate Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Coagulation Factor Concentrate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Coagulation Factor Concentrate Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Coagulation Factor Concentrate Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Coagulation Factor Concentrate Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Coagulation Factor Concentrate Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Coagulation Factor Concentrate Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Coagulation Factor Concentrate Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Recombinant Coagulation Factor Concentrate Product and Services
Table 64. Bayer Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Alprolix Basic Information, Manufacturing Base and Competitors
Table 68. Alprolix Major Business
Table 69. Alprolix Recombinant Coagulation Factor Concentrate Product and Services
Table 70. Alprolix Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Alprolix Recent Developments/Updates
Table 72. Alprolix Competitive Strengths & Weaknesses
Table 73. Benefix Basic Information, Manufacturing Base and Competitors
Table 74. Benefix Major Business
Table 75. Benefix Recombinant Coagulation Factor Concentrate Product and Services
Table 76. Benefix Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Benefix Recent Developments/Updates
Table 78. Benefix Competitive Strengths & Weaknesses
Table 79. Idelvion Basic Information, Manufacturing Base and Competitors
Table 80. Idelvion Major Business
Table 81. Idelvion Recombinant Coagulation Factor Concentrate Product and Services
Table 82. Idelvion Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Idelvion Recent Developments/Updates
Table 84. Idelvion Competitive Strengths & Weaknesses
Table 85. Lxinity Basic Information, Manufacturing Base and Competitors
Table 86. Lxinity Major Business
Table 87. Lxinity Recombinant Coagulation Factor Concentrate Product and Services
Table 88. Lxinity Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lxinity Recent Developments/Updates
Table 90. Lxinity Competitive Strengths & Weaknesses
Table 91. Rebinyn Basic Information, Manufacturing Base and Competitors
Table 92. Rebinyn Major Business
Table 93. Rebinyn Recombinant Coagulation Factor Concentrate Product and Services
Table 94. Rebinyn Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Rebinyn Recent Developments/Updates
Table 96. Rebinyn Competitive Strengths & Weaknesses
Table 97. Rixubis Basic Information, Manufacturing Base and Competitors
Table 98. Rixubis Major Business
Table 99. Rixubis Recombinant Coagulation Factor Concentrate Product and Services
Table 100. Rixubis Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Rixubis Recent Developments/Updates
Table 102. Rixubis Competitive Strengths & Weaknesses
Table 103. CSL Basic Information, Manufacturing Base and Competitors
Table 104. CSL Major Business
Table 105. CSL Recombinant Coagulation Factor Concentrate Product and Services
Table 106. CSL Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. CSL Recent Developments/Updates
Table 108. CSL Competitive Strengths & Weaknesses
Table 109. Baxalta Basic Information, Manufacturing Base and Competitors
Table 110. Baxalta Major Business
Table 111. Baxalta Recombinant Coagulation Factor Concentrate Product and Services
Table 112. Baxalta Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Baxalta Recent Developments/Updates
Table 114. Baxalta Competitive Strengths & Weaknesses
Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. Sanofi Major Business
Table 117. Sanofi Recombinant Coagulation Factor Concentrate Product and Services
Table 118. Sanofi Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sanofi Recent Developments/Updates
Table 120. Sanofi Competitive Strengths & Weaknesses
Table 121. Biogen Basic Information, Manufacturing Base and Competitors
Table 122. Biogen Major Business
Table 123. Biogen Recombinant Coagulation Factor Concentrate Product and Services
Table 124. Biogen Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Biogen Recent Developments/Updates
Table 126. Biogen Competitive Strengths & Weaknesses
Table 127. Pfizer Basic Information, Manufacturing Base and Competitors
Table 128. Pfizer Major Business
Table 129. Pfizer Recombinant Coagulation Factor Concentrate Product and Services
Table 130. Pfizer Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Pfizer Recent Developments/Updates
Table 132. Pfizer Competitive Strengths & Weaknesses
Table 133. Novo Disk Basic Information, Manufacturing Base and Competitors
Table 134. Novo Disk Major Business
Table 135. Novo Disk Recombinant Coagulation Factor Concentrate Product and Services
Table 136. Novo Disk Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Novo Disk Recent Developments/Updates
Table 138. Novo Disk Competitive Strengths & Weaknesses
Table 139. Baxter Basic Information, Manufacturing Base and Competitors
Table 140. Baxter Major Business
Table 141. Baxter Recombinant Coagulation Factor Concentrate Product and Services
Table 142. Baxter Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Baxter Recent Developments/Updates
Table 144. Baxter Competitive Strengths & Weaknesses
Table 145. Wyeth Basic Information, Manufacturing Base and Competitors
Table 146. Wyeth Major Business
Table 147. Wyeth Recombinant Coagulation Factor Concentrate Product and Services
Table 148. Wyeth Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Wyeth Recent Developments/Updates
Table 150. Wyeth Competitive Strengths & Weaknesses
Table 151. 北京天坛生物制品股份有限公司 Basic Information, Manufacturing Base and Competitors
Table 152. 北京天坛生物制品股份有限公司 Major Business
Table 153. 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Product and Services
Table 154. 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. 北京天坛生物制品股份有限公司 Recent Developments/Updates
Table 156. 北京天坛生物制品股份有限公司 Competitive Strengths & Weaknesses
Table 157. 上海莱士 Basic Information, Manufacturing Base and Competitors
Table 158. 上海莱士 Major Business
Table 159. 上海莱士 Recombinant Coagulation Factor Concentrate Product and Services
Table 160. 上海莱士 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. 上海莱士 Recent Developments/Updates
Table 162. 上海莱士 Competitive Strengths & Weaknesses
Table 163. 泰邦生物 Basic Information, Manufacturing Base and Competitors
Table 164. 泰邦生物 Major Business
Table 165. 泰邦生物 Recombinant Coagulation Factor Concentrate Product and Services
Table 166. 泰邦生物 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. 泰邦生物 Recent Developments/Updates
Table 168. 泰邦生物 Competitive Strengths & Weaknesses
Table 169. 华兰生物 Basic Information, Manufacturing Base and Competitors
Table 170. 华兰生物 Major Business
Table 171. 华兰生物 Recombinant Coagulation Factor Concentrate Product and Services
Table 172. 华兰生物 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. 华兰生物 Recent Developments/Updates
Table 174. 绿十字(中国)生物制品有限公司 Basic Information, Manufacturing Base and Competitors
Table 175. 绿十字(中国)生物制品有限公司 Major Business
Table 176. 绿十字(中国)生物制品有限公司 Recombinant Coagulation Factor Concentrate Product and Services
Table 177. 绿十字(中国)生物制品有限公司 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Recombinant Coagulation Factor Concentrate Upstream (Raw Materials)
Table 179. Recombinant Coagulation Factor Concentrate Typical Customers
Table 180. Recombinant Coagulation Factor Concentrate Typical Distributors
List of Figure
Figure 1. Recombinant Coagulation Factor Concentrate Picture
Figure 2. World Recombinant Coagulation Factor Concentrate Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Coagulation Factor Concentrate Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 5. World Recombinant Coagulation Factor Concentrate Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Coagulation Factor Concentrate Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 9. Europe Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 10. China Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 11. Japan Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 12. Recombinant Coagulation Factor Concentrate Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 15. World Recombinant Coagulation Factor Concentrate Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 17. China Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 18. Europe Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 19. Japan Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 20. South Korea Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 22. India Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Recombinant Coagulation Factor Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Coagulation Factor Concentrate Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Coagulation Factor Concentrate Markets in 2022
Figure 26. United States VS China: Recombinant Coagulation Factor Concentrate Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Coagulation Factor Concentrate Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Coagulation Factor Concentrate Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share 2022
Figure 32. World Recombinant Coagulation Factor Concentrate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Type in 2022
Figure 34. 250 IU
Figure 35. 500 IU
Figure 36. 1000 IU
Figure 37. 2000 IU
Figure 38. World Recombinant Coagulation Factor Concentrate Production Market Share by Type (2018-2029)
Figure 39. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Type (2018-2029)
Figure 40. World Recombinant Coagulation Factor Concentrate Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Recombinant Coagulation Factor Concentrate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Application in 2022
Figure 43. Hopistial
Figure 44. Clinic
Figure 45. Others
Figure 46. World Recombinant Coagulation Factor Concentrate Production Market Share by Application (2018-2029)
Figure 47. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Application (2018-2029)
Figure 48. World Recombinant Coagulation Factor Concentrate Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Recombinant Coagulation Factor Concentrate Industry Chain
Figure 50. Recombinant Coagulation Factor Concentrate Procurement Model
Figure 51. Recombinant Coagulation Factor Concentrate Sales Model
Figure 52. Recombinant Coagulation Factor Concentrate Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bayer
Alprolix
Benefix
Idelvion
Lxinity
Rebinyn
Rixubis
CSL
Baxalta
Sanofi
Biogen
Pfizer
Novo Disk
Baxter
Wyeth
北京天坛生物制品股份有限公司
上海莱士
泰邦生物
华兰生物
绿十字(中国)生物制品有限公司
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Recombinant Coagulation Factor Concentrate Supply, Demand and Key Producers, 2023-2029

Global Recombinant Coagulation Factor Concentrate Supply, Demand and Key Producers, 2023-2029

Page: 129

Published Date: 22 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Recombinant Coagulation Factor Concentrate market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

This report studies the global Recombinant Coagulation Factor Concentrate production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Coagulation Factor Concentrate, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Coagulation Factor Concentrate that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Recombinant Coagulation Factor Concentrate total production and demand, 2018-2029, (K Units)
Global Recombinant Coagulation Factor Concentrate total production value, 2018-2029, (USD Million)
Global Recombinant Coagulation Factor Concentrate production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Coagulation Factor Concentrate consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Recombinant Coagulation Factor Concentrate domestic production, consumption, key domestic manufacturers and share
Global Recombinant Coagulation Factor Concentrate production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Recombinant Coagulation Factor Concentrate production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Recombinant Coagulation Factor Concentrate production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Recombinant Coagulation Factor Concentrate market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Alprolix, Benefix, Idelvion, Lxinity, Rebinyn, Rixubis, CSL and Baxalta, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Coagulation Factor Concentrate market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Recombinant Coagulation Factor Concentrate Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Recombinant Coagulation Factor Concentrate Market, Segmentation by Type
250 IU
500 IU
1000 IU
2000 IU

Global Recombinant Coagulation Factor Concentrate Market, Segmentation by Application
Hopistial
Clinic
Others

Companies Profiled:
Bayer
Alprolix
Benefix
Idelvion
Lxinity
Rebinyn
Rixubis
CSL
Baxalta
Sanofi
Biogen
Pfizer
Novo Disk
Baxter
Wyeth
北京天坛生物制品股份有限公司
上海莱士
泰邦生物
华兰生物
绿十字(中国)生物制品有限公司

Key Questions Answered
1. How big is the global Recombinant Coagulation Factor Concentrate market?
2. What is the demand of the global Recombinant Coagulation Factor Concentrate market?
3. What is the year over year growth of the global Recombinant Coagulation Factor Concentrate market?
4. What is the production and production value of the global Recombinant Coagulation Factor Concentrate market?
5. Who are the key producers in the global Recombinant Coagulation Factor Concentrate market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Recombinant Coagulation Factor Concentrate Introduction
1.2 World Recombinant Coagulation Factor Concentrate Supply & Forecast
1.2.1 World Recombinant Coagulation Factor Concentrate Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.2.3 World Recombinant Coagulation Factor Concentrate Pricing Trends (2018-2029)
1.3 World Recombinant Coagulation Factor Concentrate Production by Region (Based on Production Site)
1.3.1 World Recombinant Coagulation Factor Concentrate Production Value by Region (2018-2029)
1.3.2 World Recombinant Coagulation Factor Concentrate Production by Region (2018-2029)
1.3.3 World Recombinant Coagulation Factor Concentrate Average Price by Region (2018-2029)
1.3.4 North America Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.3.5 Europe Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.3.6 China Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.3.7 Japan Recombinant Coagulation Factor Concentrate Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Coagulation Factor Concentrate Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Coagulation Factor Concentrate Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Recombinant Coagulation Factor Concentrate Demand (2018-2029)
2.2 World Recombinant Coagulation Factor Concentrate Consumption by Region
2.2.1 World Recombinant Coagulation Factor Concentrate Consumption by Region (2018-2023)
2.2.2 World Recombinant Coagulation Factor Concentrate Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.4 China Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.5 Europe Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.6 Japan Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.7 South Korea Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.8 ASEAN Recombinant Coagulation Factor Concentrate Consumption (2018-2029)
2.9 India Recombinant Coagulation Factor Concentrate Consumption (2018-2029)

3 World Recombinant Coagulation Factor Concentrate Manufacturers Competitive Analysis
3.1 World Recombinant Coagulation Factor Concentrate Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Coagulation Factor Concentrate Production by Manufacturer (2018-2023)
3.3 World Recombinant Coagulation Factor Concentrate Average Price by Manufacturer (2018-2023)
3.4 Recombinant Coagulation Factor Concentrate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Coagulation Factor Concentrate Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Coagulation Factor Concentrate in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Coagulation Factor Concentrate in 2022
3.6 Recombinant Coagulation Factor Concentrate Market: Overall Company Footprint Analysis
3.6.1 Recombinant Coagulation Factor Concentrate Market: Region Footprint
3.6.2 Recombinant Coagulation Factor Concentrate Market: Company Product Type Footprint
3.6.3 Recombinant Coagulation Factor Concentrate Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Recombinant Coagulation Factor Concentrate Production Value Comparison
4.1.1 United States VS China: Recombinant Coagulation Factor Concentrate Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Coagulation Factor Concentrate Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Coagulation Factor Concentrate Production Comparison
4.2.1 United States VS China: Recombinant Coagulation Factor Concentrate Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Coagulation Factor Concentrate Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Coagulation Factor Concentrate Consumption Comparison
4.3.1 United States VS China: Recombinant Coagulation Factor Concentrate Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Coagulation Factor Concentrate Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Coagulation Factor Concentrate Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023)
4.5 China Based Recombinant Coagulation Factor Concentrate Manufacturers and Market Share
4.5.1 China Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023)
4.6 Rest of World Based Recombinant Coagulation Factor Concentrate Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023)

5 Market Analysis by Type
5.1 World Recombinant Coagulation Factor Concentrate Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 250 IU
5.2.2 500 IU
5.2.3 1000 IU
5.2.4 2000 IU
5.3 Market Segment by Type
5.3.1 World Recombinant Coagulation Factor Concentrate Production by Type (2018-2029)
5.3.2 World Recombinant Coagulation Factor Concentrate Production Value by Type (2018-2029)
5.3.3 World Recombinant Coagulation Factor Concentrate Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Recombinant Coagulation Factor Concentrate Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hopistial
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Recombinant Coagulation Factor Concentrate Production by Application (2018-2029)
6.3.2 World Recombinant Coagulation Factor Concentrate Production Value by Application (2018-2029)
6.3.3 World Recombinant Coagulation Factor Concentrate Average Price by Application (2018-2029)

7 Company Profiles
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Recombinant Coagulation Factor Concentrate Product and Services
7.1.4 Bayer Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Alprolix
7.2.1 Alprolix Details
7.2.2 Alprolix Major Business
7.2.3 Alprolix Recombinant Coagulation Factor Concentrate Product and Services
7.2.4 Alprolix Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Alprolix Recent Developments/Updates
7.2.6 Alprolix Competitive Strengths & Weaknesses
7.3 Benefix
7.3.1 Benefix Details
7.3.2 Benefix Major Business
7.3.3 Benefix Recombinant Coagulation Factor Concentrate Product and Services
7.3.4 Benefix Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Benefix Recent Developments/Updates
7.3.6 Benefix Competitive Strengths & Weaknesses
7.4 Idelvion
7.4.1 Idelvion Details
7.4.2 Idelvion Major Business
7.4.3 Idelvion Recombinant Coagulation Factor Concentrate Product and Services
7.4.4 Idelvion Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Idelvion Recent Developments/Updates
7.4.6 Idelvion Competitive Strengths & Weaknesses
7.5 Lxinity
7.5.1 Lxinity Details
7.5.2 Lxinity Major Business
7.5.3 Lxinity Recombinant Coagulation Factor Concentrate Product and Services
7.5.4 Lxinity Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lxinity Recent Developments/Updates
7.5.6 Lxinity Competitive Strengths & Weaknesses
7.6 Rebinyn
7.6.1 Rebinyn Details
7.6.2 Rebinyn Major Business
7.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Product and Services
7.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Rebinyn Recent Developments/Updates
7.6.6 Rebinyn Competitive Strengths & Weaknesses
7.7 Rixubis
7.7.1 Rixubis Details
7.7.2 Rixubis Major Business
7.7.3 Rixubis Recombinant Coagulation Factor Concentrate Product and Services
7.7.4 Rixubis Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Rixubis Recent Developments/Updates
7.7.6 Rixubis Competitive Strengths & Weaknesses
7.8 CSL
7.8.1 CSL Details
7.8.2 CSL Major Business
7.8.3 CSL Recombinant Coagulation Factor Concentrate Product and Services
7.8.4 CSL Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 CSL Recent Developments/Updates
7.8.6 CSL Competitive Strengths & Weaknesses
7.9 Baxalta
7.9.1 Baxalta Details
7.9.2 Baxalta Major Business
7.9.3 Baxalta Recombinant Coagulation Factor Concentrate Product and Services
7.9.4 Baxalta Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Baxalta Recent Developments/Updates
7.9.6 Baxalta Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi Recombinant Coagulation Factor Concentrate Product and Services
7.10.4 Sanofi Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Biogen
7.11.1 Biogen Details
7.11.2 Biogen Major Business
7.11.3 Biogen Recombinant Coagulation Factor Concentrate Product and Services
7.11.4 Biogen Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Biogen Recent Developments/Updates
7.11.6 Biogen Competitive Strengths & Weaknesses
7.12 Pfizer
7.12.1 Pfizer Details
7.12.2 Pfizer Major Business
7.12.3 Pfizer Recombinant Coagulation Factor Concentrate Product and Services
7.12.4 Pfizer Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Pfizer Recent Developments/Updates
7.12.6 Pfizer Competitive Strengths & Weaknesses
7.13 Novo Disk
7.13.1 Novo Disk Details
7.13.2 Novo Disk Major Business
7.13.3 Novo Disk Recombinant Coagulation Factor Concentrate Product and Services
7.13.4 Novo Disk Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Novo Disk Recent Developments/Updates
7.13.6 Novo Disk Competitive Strengths & Weaknesses
7.14 Baxter
7.14.1 Baxter Details
7.14.2 Baxter Major Business
7.14.3 Baxter Recombinant Coagulation Factor Concentrate Product and Services
7.14.4 Baxter Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Baxter Recent Developments/Updates
7.14.6 Baxter Competitive Strengths & Weaknesses
7.15 Wyeth
7.15.1 Wyeth Details
7.15.2 Wyeth Major Business
7.15.3 Wyeth Recombinant Coagulation Factor Concentrate Product and Services
7.15.4 Wyeth Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Wyeth Recent Developments/Updates
7.15.6 Wyeth Competitive Strengths & Weaknesses
7.16 北京天坛生物制品股份有限公司
7.16.1 北京天坛生物制品股份有限公司 Details
7.16.2 北京天坛生物制品股份有限公司 Major Business
7.16.3 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Product and Services
7.16.4 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 北京天坛生物制品股份有限公司 Recent Developments/Updates
7.16.6 北京天坛生物制品股份有限公司 Competitive Strengths & Weaknesses
7.17 上海莱士
7.17.1 上海莱士 Details
7.17.2 上海莱士 Major Business
7.17.3 上海莱士 Recombinant Coagulation Factor Concentrate Product and Services
7.17.4 上海莱士 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 上海莱士 Recent Developments/Updates
7.17.6 上海莱士 Competitive Strengths & Weaknesses
7.18 泰邦生物
7.18.1 泰邦生物 Details
7.18.2 泰邦生物 Major Business
7.18.3 泰邦生物 Recombinant Coagulation Factor Concentrate Product and Services
7.18.4 泰邦生物 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 泰邦生物 Recent Developments/Updates
7.18.6 泰邦生物 Competitive Strengths & Weaknesses
7.19 华兰生物
7.19.1 华兰生物 Details
7.19.2 华兰生物 Major Business
7.19.3 华兰生物 Recombinant Coagulation Factor Concentrate Product and Services
7.19.4 华兰生物 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 华兰生物 Recent Developments/Updates
7.19.6 华兰生物 Competitive Strengths & Weaknesses
7.20 绿十字(中国)生物制品有限公司
7.20.1 绿十字(中国)生物制品有限公司 Details
7.20.2 绿十字(中国)生物制品有限公司 Major Business
7.20.3 绿十字(中国)生物制品有限公司 Recombinant Coagulation Factor Concentrate Product and Services
7.20.4 绿十字(中国)生物制品有限公司 Recombinant Coagulation Factor Concentrate Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 绿十字(中国)生物制品有限公司 Recent Developments/Updates
7.20.6 绿十字(中国)生物制品有限公司 Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Recombinant Coagulation Factor Concentrate Industry Chain
8.2 Recombinant Coagulation Factor Concentrate Upstream Analysis
8.2.1 Recombinant Coagulation Factor Concentrate Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Coagulation Factor Concentrate Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Coagulation Factor Concentrate Production Mode
8.6 Recombinant Coagulation Factor Concentrate Procurement Model
8.7 Recombinant Coagulation Factor Concentrate Industry Sales Model and Sales Channels
8.7.1 Recombinant Coagulation Factor Concentrate Sales Model
8.7.2 Recombinant Coagulation Factor Concentrate Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Recombinant Coagulation Factor Concentrate Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Coagulation Factor Concentrate Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Coagulation Factor Concentrate Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Coagulation Factor Concentrate Production by Region (2018-2023) & (K Units)
Table 7. World Recombinant Coagulation Factor Concentrate Production by Region (2024-2029) & (K Units)
Table 8. World Recombinant Coagulation Factor Concentrate Production Market Share by Region (2018-2023)
Table 9. World Recombinant Coagulation Factor Concentrate Production Market Share by Region (2024-2029)
Table 10. World Recombinant Coagulation Factor Concentrate Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Coagulation Factor Concentrate Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Coagulation Factor Concentrate Major Market Trends
Table 13. World Recombinant Coagulation Factor Concentrate Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Recombinant Coagulation Factor Concentrate Consumption by Region (2018-2023) & (K Units)
Table 15. World Recombinant Coagulation Factor Concentrate Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Recombinant Coagulation Factor Concentrate Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Coagulation Factor Concentrate Producers in 2022
Table 18. World Recombinant Coagulation Factor Concentrate Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Recombinant Coagulation Factor Concentrate Producers in 2022
Table 20. World Recombinant Coagulation Factor Concentrate Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Coagulation Factor Concentrate Company Evaluation Quadrant
Table 22. World Recombinant Coagulation Factor Concentrate Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Coagulation Factor Concentrate Production Site of Key Manufacturer
Table 24. Recombinant Coagulation Factor Concentrate Market: Company Product Type Footprint
Table 25. Recombinant Coagulation Factor Concentrate Market: Company Product Application Footprint
Table 26. Recombinant Coagulation Factor Concentrate Competitive Factors
Table 27. Recombinant Coagulation Factor Concentrate New Entrant and Capacity Expansion Plans
Table 28. Recombinant Coagulation Factor Concentrate Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Coagulation Factor Concentrate Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Coagulation Factor Concentrate Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Recombinant Coagulation Factor Concentrate Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share (2018-2023)
Table 37. China Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Coagulation Factor Concentrate Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share (2018-2023)
Table 47. World Recombinant Coagulation Factor Concentrate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Coagulation Factor Concentrate Production by Type (2018-2023) & (K Units)
Table 49. World Recombinant Coagulation Factor Concentrate Production by Type (2024-2029) & (K Units)
Table 50. World Recombinant Coagulation Factor Concentrate Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Coagulation Factor Concentrate Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Coagulation Factor Concentrate Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Coagulation Factor Concentrate Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Coagulation Factor Concentrate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Coagulation Factor Concentrate Production by Application (2018-2023) & (K Units)
Table 56. World Recombinant Coagulation Factor Concentrate Production by Application (2024-2029) & (K Units)
Table 57. World Recombinant Coagulation Factor Concentrate Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Coagulation Factor Concentrate Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Coagulation Factor Concentrate Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Coagulation Factor Concentrate Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Recombinant Coagulation Factor Concentrate Product and Services
Table 64. Bayer Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Alprolix Basic Information, Manufacturing Base and Competitors
Table 68. Alprolix Major Business
Table 69. Alprolix Recombinant Coagulation Factor Concentrate Product and Services
Table 70. Alprolix Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Alprolix Recent Developments/Updates
Table 72. Alprolix Competitive Strengths & Weaknesses
Table 73. Benefix Basic Information, Manufacturing Base and Competitors
Table 74. Benefix Major Business
Table 75. Benefix Recombinant Coagulation Factor Concentrate Product and Services
Table 76. Benefix Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Benefix Recent Developments/Updates
Table 78. Benefix Competitive Strengths & Weaknesses
Table 79. Idelvion Basic Information, Manufacturing Base and Competitors
Table 80. Idelvion Major Business
Table 81. Idelvion Recombinant Coagulation Factor Concentrate Product and Services
Table 82. Idelvion Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Idelvion Recent Developments/Updates
Table 84. Idelvion Competitive Strengths & Weaknesses
Table 85. Lxinity Basic Information, Manufacturing Base and Competitors
Table 86. Lxinity Major Business
Table 87. Lxinity Recombinant Coagulation Factor Concentrate Product and Services
Table 88. Lxinity Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lxinity Recent Developments/Updates
Table 90. Lxinity Competitive Strengths & Weaknesses
Table 91. Rebinyn Basic Information, Manufacturing Base and Competitors
Table 92. Rebinyn Major Business
Table 93. Rebinyn Recombinant Coagulation Factor Concentrate Product and Services
Table 94. Rebinyn Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Rebinyn Recent Developments/Updates
Table 96. Rebinyn Competitive Strengths & Weaknesses
Table 97. Rixubis Basic Information, Manufacturing Base and Competitors
Table 98. Rixubis Major Business
Table 99. Rixubis Recombinant Coagulation Factor Concentrate Product and Services
Table 100. Rixubis Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Rixubis Recent Developments/Updates
Table 102. Rixubis Competitive Strengths & Weaknesses
Table 103. CSL Basic Information, Manufacturing Base and Competitors
Table 104. CSL Major Business
Table 105. CSL Recombinant Coagulation Factor Concentrate Product and Services
Table 106. CSL Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. CSL Recent Developments/Updates
Table 108. CSL Competitive Strengths & Weaknesses
Table 109. Baxalta Basic Information, Manufacturing Base and Competitors
Table 110. Baxalta Major Business
Table 111. Baxalta Recombinant Coagulation Factor Concentrate Product and Services
Table 112. Baxalta Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Baxalta Recent Developments/Updates
Table 114. Baxalta Competitive Strengths & Weaknesses
Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. Sanofi Major Business
Table 117. Sanofi Recombinant Coagulation Factor Concentrate Product and Services
Table 118. Sanofi Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sanofi Recent Developments/Updates
Table 120. Sanofi Competitive Strengths & Weaknesses
Table 121. Biogen Basic Information, Manufacturing Base and Competitors
Table 122. Biogen Major Business
Table 123. Biogen Recombinant Coagulation Factor Concentrate Product and Services
Table 124. Biogen Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Biogen Recent Developments/Updates
Table 126. Biogen Competitive Strengths & Weaknesses
Table 127. Pfizer Basic Information, Manufacturing Base and Competitors
Table 128. Pfizer Major Business
Table 129. Pfizer Recombinant Coagulation Factor Concentrate Product and Services
Table 130. Pfizer Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Pfizer Recent Developments/Updates
Table 132. Pfizer Competitive Strengths & Weaknesses
Table 133. Novo Disk Basic Information, Manufacturing Base and Competitors
Table 134. Novo Disk Major Business
Table 135. Novo Disk Recombinant Coagulation Factor Concentrate Product and Services
Table 136. Novo Disk Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Novo Disk Recent Developments/Updates
Table 138. Novo Disk Competitive Strengths & Weaknesses
Table 139. Baxter Basic Information, Manufacturing Base and Competitors
Table 140. Baxter Major Business
Table 141. Baxter Recombinant Coagulation Factor Concentrate Product and Services
Table 142. Baxter Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Baxter Recent Developments/Updates
Table 144. Baxter Competitive Strengths & Weaknesses
Table 145. Wyeth Basic Information, Manufacturing Base and Competitors
Table 146. Wyeth Major Business
Table 147. Wyeth Recombinant Coagulation Factor Concentrate Product and Services
Table 148. Wyeth Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Wyeth Recent Developments/Updates
Table 150. Wyeth Competitive Strengths & Weaknesses
Table 151. 北京天坛生物制品股份有限公司 Basic Information, Manufacturing Base and Competitors
Table 152. 北京天坛生物制品股份有限公司 Major Business
Table 153. 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Product and Services
Table 154. 北京天坛生物制品股份有限公司 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. 北京天坛生物制品股份有限公司 Recent Developments/Updates
Table 156. 北京天坛生物制品股份有限公司 Competitive Strengths & Weaknesses
Table 157. 上海莱士 Basic Information, Manufacturing Base and Competitors
Table 158. 上海莱士 Major Business
Table 159. 上海莱士 Recombinant Coagulation Factor Concentrate Product and Services
Table 160. 上海莱士 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. 上海莱士 Recent Developments/Updates
Table 162. 上海莱士 Competitive Strengths & Weaknesses
Table 163. 泰邦生物 Basic Information, Manufacturing Base and Competitors
Table 164. 泰邦生物 Major Business
Table 165. 泰邦生物 Recombinant Coagulation Factor Concentrate Product and Services
Table 166. 泰邦生物 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. 泰邦生物 Recent Developments/Updates
Table 168. 泰邦生物 Competitive Strengths & Weaknesses
Table 169. 华兰生物 Basic Information, Manufacturing Base and Competitors
Table 170. 华兰生物 Major Business
Table 171. 华兰生物 Recombinant Coagulation Factor Concentrate Product and Services
Table 172. 华兰生物 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. 华兰生物 Recent Developments/Updates
Table 174. 绿十字(中国)生物制品有限公司 Basic Information, Manufacturing Base and Competitors
Table 175. 绿十字(中国)生物制品有限公司 Major Business
Table 176. 绿十字(中国)生物制品有限公司 Recombinant Coagulation Factor Concentrate Product and Services
Table 177. 绿十字(中国)生物制品有限公司 Recombinant Coagulation Factor Concentrate Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Recombinant Coagulation Factor Concentrate Upstream (Raw Materials)
Table 179. Recombinant Coagulation Factor Concentrate Typical Customers
Table 180. Recombinant Coagulation Factor Concentrate Typical Distributors
List of Figure
Figure 1. Recombinant Coagulation Factor Concentrate Picture
Figure 2. World Recombinant Coagulation Factor Concentrate Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Coagulation Factor Concentrate Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 5. World Recombinant Coagulation Factor Concentrate Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Coagulation Factor Concentrate Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 9. Europe Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 10. China Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 11. Japan Recombinant Coagulation Factor Concentrate Production (2018-2029) & (K Units)
Figure 12. Recombinant Coagulation Factor Concentrate Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 15. World Recombinant Coagulation Factor Concentrate Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 17. China Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 18. Europe Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 19. Japan Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 20. South Korea Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 22. India Recombinant Coagulation Factor Concentrate Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Recombinant Coagulation Factor Concentrate by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Coagulation Factor Concentrate Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Coagulation Factor Concentrate Markets in 2022
Figure 26. United States VS China: Recombinant Coagulation Factor Concentrate Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Coagulation Factor Concentrate Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Coagulation Factor Concentrate Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Coagulation Factor Concentrate Production Market Share 2022
Figure 32. World Recombinant Coagulation Factor Concentrate Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Type in 2022
Figure 34. 250 IU
Figure 35. 500 IU
Figure 36. 1000 IU
Figure 37. 2000 IU
Figure 38. World Recombinant Coagulation Factor Concentrate Production Market Share by Type (2018-2029)
Figure 39. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Type (2018-2029)
Figure 40. World Recombinant Coagulation Factor Concentrate Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Recombinant Coagulation Factor Concentrate Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Application in 2022
Figure 43. Hopistial
Figure 44. Clinic
Figure 45. Others
Figure 46. World Recombinant Coagulation Factor Concentrate Production Market Share by Application (2018-2029)
Figure 47. World Recombinant Coagulation Factor Concentrate Production Value Market Share by Application (2018-2029)
Figure 48. World Recombinant Coagulation Factor Concentrate Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Recombinant Coagulation Factor Concentrate Industry Chain
Figure 50. Recombinant Coagulation Factor Concentrate Procurement Model
Figure 51. Recombinant Coagulation Factor Concentrate Sales Model
Figure 52. Recombinant Coagulation Factor Concentrate Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bayer
Alprolix
Benefix
Idelvion
Lxinity
Rebinyn
Rixubis
CSL
Baxalta
Sanofi
Biogen
Pfizer
Novo Disk
Baxter
Wyeth
北京天坛生物制品股份有限公司
上海莱士
泰邦生物
华兰生物
绿十字(中国)生物制品有限公司
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now